Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts
- 18 August 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 347 (1) , 31-35
- https://doi.org/10.1016/j.bbrc.2006.06.052
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Expression of platelet‐derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritisArthritis & Rheumatism, 2006
- Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritisAnnals of the Rheumatic Diseases, 2005
- Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinibBlood, 2005
- Platelet-Derived Growth Factor-AA Increases IL-1beta and IL-8 Expression and Activates NF-kappaB in Rheumatoid Fibroblast-Like SynoviocytesScandinavian Journal of Immunology, 2004
- Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemiaClinical Rheumatology, 2003
- Evolving concepts of rheumatoid arthritisNature, 2003
- Apoptosis as a therapeutic tool in rheumatoid arthritisNature Reviews Immunology, 2002
- Gene expression profile analysis of rheumatoid synovial fibroblast cultures revealing the overexpression of genes responsible for tumor-like growth of rheumatoid synoviumBiochemical and Biophysical Research Communications, 2002
- Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alphaClinical and Experimental Immunology, 1991
- Expression of Platelet‐Derived Growth Factor Receptors is Induced on Connective Tissue Cells During Chronic Synovial InflammationScandinavian Journal of Immunology, 1988